science top stories popular news  

Daily non-political popular news in brief.

Restrictive provincial drug policies may have benefits

12-04-2006 · EurekAlert!

Mamdani and co-authors report on their comparison of changes over time in NSAID use and upper GI bleeding rates in British Columbia, which restricts the use of these drugs, and in Ontario, which has a less restrictive drug coverage policy. Their findings suggest that a more restrictive drug coverage policy, although limiting access to drugs and their potential benefits, may protect the population from adverse drug effects.

Read more »

Keywords: restrictive, provincial, drug, policies, benefits, policy, benefit

« Previous | Next »

Similar news on "Restrictive provincial drug policies may have benefits":

  1. IDSA urges Congress to support Hatch amendments
    04-26-2007 · EurekAlert!
    The Infectious Diseases Society of American is calling on members of Congress to support the "Antibiotic Safety and Innovation" amendment introduced by Sen. Orrin Hatch (R-UT) to the Food Drug Administration Revitalization Act. Without innovative public policy, the practice of medicine may return to the pre-antibiotic era when acquiring a bacterial infection was often a death sentence.
    Similar news · Read more »
  2. Exercise can reduce a smoker's lung cancer risk, but quitting smoking is still most important
    12-11-2006 · EurekAlert!
    In a study of more than 36,000 women, researchers observed that smokers can reduce their risk of developing lung cancer by being physically active. However, they strongly caution that any relative benefit is dwarfed by the benefits gained from quitting smoking.
    Similar news · Read more »
  3. NIH scientists describe ways to better assess benefits of influenza vaccine in the elderly
    09-24-2007 · EurekAlert!
    Each year, seasonal flu kills approximately 36,000 people in the United States, most over age 70. Yet little is known about the benefit of influenza vaccine in older seniors. In an article in the October issue of the Lancet Infectious Diseases, researchers from NIH describe how sources of bias in other, non-randomized studies have inadvertently resulted in an exaggeration of the flu vaccine's value in preventing flu deaths in the elderly.
    Similar news · Read more »
  4. Not just humans benefit from animal biotechnology
    10-24-2007 · EurekAlert!
    Laboratory animals are the source of major discoveries and breakthroughs in biology, not just in tackling disease but also unravelling fundamental molecular processes. Delegates at a recent research conference organized by the European Science Foundation and Wellcome Trust heard how technology capable of analysing animal genes across the whole genome is yielding many benefits for agriculture and human society.
    Similar news · Read more »
  5. Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese
    11-01-2006 · EurekAlert!
    Researchers have used a single compound to increase the lifespan of obese mice, and found that the drug reversed nearly all of the changes in gene expression patterns found in mice on high calorie diets -- some of which are associated with diabetes, heart disease and other significant diseases related to obesity. The research is the first time that the small molecule resveratrol has been shown to offer survival benefits in a mammal.
    Similar news · Read more »
  6. What are the benefits and risks of fitting patients with radiofrequency identification devices?
    11-26-2007 · EurekAlert!
    In 2004, the United States Food and Drug Administration approved a radiofrequency identification device that is implanted under the skin of the upper arm of patients and that stores the patient's medical identifier. A debate in this week's PLoS Medicine discusses the pros and cons of patients getting fitted with such an RFID chip.
    Similar news · Read more »
  7. Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs
    12-28-2007 · EurekAlert!
    Current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems, according to a recent presentation made by Dr. Jeffrey Borer, an authority in cardiovascular medicine and surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.
    Similar news · Read more »
  8. Tip sheet for Annals of Internal Medicine -- May 1, 2007, issue
    04-30-2007 · EurekAlert!
    Two studies in the May 1, 2007, Annals of Internal Medicine find that infliximab, a widely used anti-tumor necrosis drug, has no benefit in patients receiving standard corticosteroid treatment for giant-cell arteritis or polymyalgia rheumatica.
    Similar news · Read more »
  9. Draft national policy on sight-saving drugs 'unacceptable'
    07-02-2007 · EurekAlert!
    Restricting use of drugs for macular degeneration to patients who have already gone blind in one eye is "unacceptable" concludes the July issue of Drug and Therapeutics Bulletin (DTB).But that is what the National Institute for Health and Clinical Excellence (NICE), the body responsible for guiding the NHS on which treatments to use, is proposing.
    Similar news · Read more »
  10. Injection drug use and HIV and HCV infections among Ontario prison inmates
    07-30-2007 · EurekAlert!
    In this issue of CMAJ, two research groups report on the prevalence of HIV and hepatitis C virus infections in different inmate populations: people in provincial prisons in Quebec, and adult and young offenders admitted to remand facilities (jails, detention centres and youth centers) in Ontario. The Ontario study is highlighted below; the Quebec study appears in a separate release posted on EurekAlert today.
    Similar news · Read more »